Increased CD19+CD24+CD27+ B Regulatory Cells Are Associated with Insulin Resistance in Patients with Type I Hashimoto's Thyroiditis

Min Yang,Changji Du,Yinping Wang,Jun Liu
DOI: https://doi.org/10.3892/mmr.2017.6507
IF: 3.423
2017-01-01
Molecular Medicine Reports
Abstract:Hashimoto's thyroiditis (HT) is characterized by dysregulated immune responses and is commonly associated with insulin resistance. However, the mechanism of insulin resistance in HT remains to be fully elucidated. The aim of the present study was to investigate the correlation between the percentage of B regulatory lymphocytes (Bregs) and insulin resistance in patients with HT but with normal thyroid function (type I). A total of 59 patients with type I HT and 38 healthy volunteers were enrolled in the study. An oral glucose tolerance test was performed to measure insulin secretion and assess beta-cell functions. Flow cytometry was performed to examine the percentages of lymphocyte populations. The patients with HT exhibited normal fasting and postprandial glucose and fasting insulin secretion, but increased secretion of early-phase and total insulin. The patients with HT also had insufficient beta-cell compensation for insulin resistance, indicated by a reduced disposition index, in the fasting state. An elevation in the percentage of CD19(+)CD24(+)CD27(+) Bregs was also observed, which correlated positively with insulin secretion and insulin resistance in the fasting state. The patients with type I HT had postprandial insulin resistance and insufficient beta-cell compensation for fasting insulin resistance. Therefore, the increase in CD19(+)CD24(+)CD27(+) Bregs was closely associated with fasting insulin secretion. These results provide novel insight into the mechanism of insulin resistance in HT.
What problem does this paper attempt to address?